JAN 29, 2016 08:07 AM PST

Precision Medicine for Brain Tumors

WRITTEN BY: Xuan Pham
Brain tumors can be rapidly profiled with new gene test

Precision medicine makes its way to one of the most complicated organs in the body: the brain. Researchers from the University of Pittsburgh School of Medicine have developed a new sequencing test that can rapidly profile brain tumors and guide the treatment of brain cancers.

Whether it’s a primary tumor or one that’s metastasized, brain cancer remains one of the scariest diagnoses that a patient can receive. According to the American Brain Tumor Association, every year nearly 70,000 new cases of primary brain cancers will be diagnosed. And every year, 14,000 people will succumb to the disease.
 
"The diagnosis of brain tumors has been based primarily on cellular features seen under the microscope," said Dr. Marina Nikiforova, senior investigator and director of UPMC's Molecular & Genomic Pathology Laboratory. "However, patients with tumors that look identical may experience different clinical outcomes and responses to treatment because the underlying genetic characteristics of their tumors differ.”
 
To find the underlying genetic changes in brain tumors, Dr. Nikiforova and her team designed a genetic sequencing panel that simultaneously analyzes 68 of the most commonly mutated genes associated with brain cancers. The test, called GlioSeq™, is performed using DNA from very small biopsy tissues from the brain cancers.
 
In a performance evaluation of 54 adults and pediatric brain cancer samples, GlioSeq correctly identified, with 100% accuracy, all the genetic alterations that are known from conventional assays. This included all single nucleotide variants, small deletions and insertions, gene fusions, and copy number variations.
 
“We designed this panel to quickly identify those traits from very small biopsies of the brain lesion,” said Dr. Nikiforova. Indeed, the test uses next-generation sequencing, a platform that’s heralded for its speed and affordability. And unlike other conventional assays, GlioSeq requires the tiniest amounts of genetic materials for analysis (20 ng of DNA, and 10 ng of RNA).
 
Most importantly, GlioSeq provides clinicians with personalized genetic information on a patient’s brain tumor. With this genetic profile, doctors can accurately classify the tumor type, which is the first step in developing a targeted treatment plan that’s tailored for the patient. Knowing the mutated genes could also allow doctors to better predict patient survival as they can anticipate patient response to certain therapies.
 
"Using GlioSeq™ helps us to understand in detail the genetic profile of brain tumors, and takes us one step closer to personalized management of our patients," Dr. Nikiforova said. "We are also working on further improving this test to include additional, recently discovered molecular alterations." 

Interested in how next-generation sequencing works? Watch this video for an amusing and unforgettable explanation.
 

Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 07, 2018
Genetics & Genomics
JUN 07, 2018
Easily Identifying Pregnancies at Risk for Premature Birth
Premature birth affects almost ten percent of pregnancies and is the leading cause of infant mortality in the US....
JUN 18, 2018
Immunology
JUN 18, 2018
Detecting and Diagnosing Rheumatoid Arthritis Before it Begins
Unique gene signatures and tiny changes in the immune system that occur in the earliest stages of rheumatoid arthritis, an autoimmune disease, could soon b...
AUG 16, 2018
Clinical & Molecular DX
AUG 16, 2018
Bubbles and a blood test could detect brain tumors
Researchers have developed a proof-of-concept technique that allows them to detect brain tumor biomarkers with a simple blood test, rather than a complicat...
NOV 21, 2018
Cardiology
NOV 21, 2018
What We Know About Kawasaki Disease
Kawasaki disease discovered by Dr. Tomisaku Kawasaki, a Japanese pediatrician, is a rare type of vasculitis, or inflammation of the blood vessels. It&rsquo...
NOV 30, 2018
Immunology
NOV 30, 2018
Aspirin May Impove MS Symptoms
The medical benefits of aspirin have been known since ancient times. Hippocrates, c. 400 BC, prescribed the salicylate-rich bark and leaves of the willow t...
DEC 08, 2018
Cardiology
DEC 08, 2018
Atrial Fibrillation, Explained
Atrial fibrillation (A-Fib) is a term you've likely heard before. You may have even been told you live with A-Fib. What exactly is this common type of...
Loading Comments...